Previous 10 | Next 10 |
2023-09-14 08:18:18 ET More on Abcam ADS Seeking Alpha’s Quant Rating on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam ticks higher as founder Milner says Danaher deal undervalues company Abcam f...
2023-09-13 16:02:03 ET Summary On July 25, 2023, GE HealthCare Technologies, one of the leading companies in developing and commercializing medical devices and pharmaceutical diagnostics, published financial results for the second quarter of 2023. GE HealthCare's revenue amounted ...
2023-09-13 00:33:55 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value increased from $21.31B to $24.43B this quarter. The number of holdings in the portfolio increased from 49 to 86. The largest five individual stock positions in the portfolio are Visa, Danaher, APi...
2023-09-12 05:16:01 ET Summary Dan Loeb's 13F portfolio value increased from $6.11B to $6.82B this quarter. The top three holdings account for approximately 31% of the entire portfolio. New stakes include Amazon, Taiwan Semi, Nvidia, and Intercontinental Exchange, among others...
2023-09-04 11:00:02 ET Summary Danaher is a highly regulated oligopoly with a strong management team and high recurrent demand, making it an outstanding business. The company operates in the healthcare field, manufacturing laboratory equipment and consumables used in drug developm...
2023-09-01 10:13:53 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam: Nosebleed Valuations, Flat Growth Profile Justify Hold Rating Abcam cut to market perform at Leerink, sees no antitrust risk ...
Danaher and Veralto to Webcast Investor and Analyst Meeting PR Newswire WASHINGTON , Aug. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto's Investor and Analyst Meeting on September 6, 2023 beginning at appro...
2023-08-31 10:53:12 ET Abcam ( NASDAQ: ABCM ) founder and large shareholder Jonathan Milner is still evaluating Danaher's $24-a-share planned takeover of the company announced on Monday. Milner is said to have set certain expectations for the company's value, and if they aren't ...
2023-08-31 10:30:00 ET Summary This article presents the highest-quality Dividend Challengers, companies listed on U.S. exchanges with consistently higher annual dividend payouts for 5-9 years. The top 20 highest-quality Dividend Challengers are identified based on a quality ...
2023-08-30 14:56:32 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam: Nosebleed Valuations, Flat Growth Profile Justify Hold Rating Abcam gains on reports Danaher in lead to acquire company Seek...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...